Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 312.50 | 180.33 | 432.00 | 276.75 | 1.5610 | 3.1116 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 312.50 | 180.33 | 178.00 | 276.75 | 0.6432 | -0.0209 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 312.50 | 180.33 | 291.00 | 276.75 | 1.0515 | 1.1693 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 405.00 | 276.75 | 1.4634 | 2.7038 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 420.00 | 276.75 | 1.5176 | 2.9284 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 312.50 | 180.33 | 339.00 | 276.75 | 1.2249 | 1.7773 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 312.50 | 180.33 | 223.00 | 276.75 | 0.8058 | 0.4101 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 256.00 | 276.75 | 0.9250 | 0.7630 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 309.00 | 276.75 | 1.1165 | 1.3906 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 312.50 | 180.33 | 154.00 | 276.75 | 0.5565 | -0.2254 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 283.00 | 276.75 | 1.0226 | 1.0736 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 366.00 | 276.75 | 1.3225 | 2.1440 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 337.00 | 276.75 | 1.2177 | 1.7508 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 312.50 | 180.33 | 173.00 | 276.75 | 0.6251 | -0.0650 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 234.00 | 276.75 | 0.8455 | 0.5244 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 230.00 | 276.75 | 0.8311 | 0.4825 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 738.00 | 823.25 | 0.8965 | 0.8107 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 913.00 | 823.25 | 1.1090 | 1.1974 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 625.00 | 384.25 | 823.00 | 823.25 | 0.9997 | 0.9995 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 317.00 | 823.25 | 0.3851 | -0.1606 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 625.00 | 384.25 | 639.00 | 823.25 | 0.7762 | 0.5883 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 625.00 | 384.25 | 848.00 | 823.25 | 1.0301 | 1.0546 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 486.00 | 823.25 | 0.5903 | 0.2383 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 625.00 | 384.25 | 606.00 | 823.25 | 0.7361 | 0.5135 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 625.00 | 384.25 | 801.00 | 823.25 | 0.9730 | 0.9508 |